Advertisement

 

 

Predicting Survival in Non-Squamous NSCLC

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

A 14-gene, quantitative-polymerase chain reaction-based assay appears to reliably identify patients with early-stage non-small-cell lung cancer (NSCLC) who are at high risk for mortality after surgical resection. The assay was designed to improve risk stratification in patients with non-squamous NSCLC.

Abstract: Lancet, January 27, 2012.

Submit a Comment

Your email address will not be published. Required fields are marked *

twenty − four =

[ HIDE/SHOW ]